USANA Health Sciences

USANA Health Sciences

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$250,218
$226,200
$213,670
$235,848
Gross Profit
190,782
176,792
164,855
177,921
EBITDA
25,494
14,586
11,410
28,680
EBIT
15,705
4,300
1,843
19,076
Net Income
7,515
-1,775
-6,522
9,655
Net Change In Cash
250,218
226,200
213,670
235,848
Free Cash Flow
7,114
-6,185
-5,159
7,191
Cash
162,751
158,380
145,349
151,338
Basic Shares
18,411
18,302
18,293
18,536

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$925,257
$854,503
$921,010
$998,601
Gross Profit
724,405
678,752
731,615
804,711
EBITDA
82,071
98,861
123,110
129,024
EBIT
42,369
76,632
102,715
107,614
Net Income
10,760
42,030
63,788
69,350
Net Change In Cash
925,257
854,503
921,010
998,601
Free Cash Flow
8,526
50,919
56,147
93,502
Cash
158,380
181,768
330,420
288,420
Basic Shares
18,574
19,162
19,345
19,310

Earnings Calls

QuarterEPS
2026-03-31
$0.61
2025-12-31
$0.60
2025-09-30
-$0.36
2025-06-30
$0.74